Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Feb 4, 2013
Company News
AmorChem, McGill University, Florida Institute of Technology deal
...asthma. AmorChem said the deal will target the "animal proof of concept" of the compounds.
MSBi Valorisation Inc.
...
Read More
BioCentury
|
Mar 7, 2011
Financial News
Mimetogen completes venture financing
...Date completed: 2/25/11 Type: Venture financing Raised: Not disclosed Investors: Medwell Capital Corp.; iNovia Capital;
MSBi Valorisation Inc.
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Feb 4, 2013
Company News
AmorChem, McGill University, Florida Institute of Technology deal
...asthma. AmorChem said the deal will target the "animal proof of concept" of the compounds.
MSBi Valorisation Inc.
...
Read More
BioCentury
|
Mar 7, 2011
Financial News
Mimetogen completes venture financing
...Date completed: 2/25/11 Type: Venture financing Raised: Not disclosed Investors: Medwell Capital Corp.; iNovia Capital;
MSBi Valorisation Inc.
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page